Citadel Advisors - CARDIOL THERAPEUTICS INC ownership

CARDIOL THERAPEUTICS INC's ticker is CRTPF and the CUSIP is 14161Y200. A total of 28 filers reported holding CARDIOL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CARDIOL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$15,791
+39.6%
17,743
-23.6%
0.00%
Q1 2023$11,313
-26.1%
23,216
-22.6%
0.00%
Q4 2022$15,300
-88.1%
30,000
-75.9%
0.00%
Q3 2022$129,000
+81.7%
124,404
+133.0%
0.00%
Q2 2022$71,000
-45.4%
53,391
-36.6%
0.00%
Q1 2022$130,000
-78.4%
84,252
-74.0%
0.00%
Q4 2021$601,000324,5690.00%
Other shareholders
CARDIOL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 3,253,400$4,978,0000.29%
Vident Investment Advisory, LLC 126,157$195,0000.01%
Marble Harbor Investment Counsel, LLC 28,900$44,0000.01%
Private Ocean, LLC 20,651$32,0000.00%
Belvedere Trading LLC 80,200$146,0000.00%
COMMONS CAPITAL, LLC 2,500$4,0000.00%
Robertson Stephens Wealth Management, LLC 27,855$42,0000.00%
VALLEY NATIONAL ADVISERS INC 5,000$8,0000.00%
Mirae Asset Global Investments Co., Ltd. 1,388,836$2,146,0000.00%
Belvedere Trading LLC 16,010$29,0000.00%
View complete list of CARDIOL THERAPEUTICS INC shareholders